Man

Rafael Ignacio Araos Bralic

Principal Investigator

Universidad del De

Santiago, Chile

Líneas de Investigación


I study the epidemiology of infectious diseases with a focus on emerging respiratory pathogens and antimicrobial-resistant bacteria. I have designed, executed, and analyzed cohort studies in Chile and abroad.

Educación

  •  MD, UNIVERSIDAD DE LOS ANDES. Chile, 2003
  •  Internal Medicine, UNIVERSIDAD DE CHILE. Chile, 2007
  •  Infectious Diseases, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2009
  •  Master in Medical Sciences, HARVARD UNIVERSITY. Estados Unidos, 2014

Experiencia Académica

  •   Principal Investigator Full Time

    UNIVERSIDAD DEL DESARROLLO

    Santiago, Chile

    2016 - A la fecha

  •   Post doctoral fellow Full Time

    Beth Israel Deaconess Medical Center

    Boston, Estados Unidos

    2012 - 2015

Experiencia Profesional

  •   Chief Epidemiology Department, Chief Covid-19 Advisor, Undersecretary of Public Health Full Time

    Ministry of Health

    Santiago, Chile

    2020 - 2022

  •   Chief, Division of Infectious Diseases Full Time

    Clínica Alemana de Santiago

    Santiago, Chile

    2015 - 2020

  •   External Advisor (Consejo Asesor Covid-19, now Comité Nacional de Respuesta Pandémica) Other

    Ministry of Health

    Santiago, Chile

    2020 - A la fecha


 

Article (27)

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Children and Adolescents: A Large-Scale Observational Study
Effectiveness of CoronaVac in children 3 to 5 years during the omicron SARS-CoV-2 outbreak
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
Effectiveness of an Inactivated SARS-CoV-2 Vaccine. Reply.
Evaluation of two fluorescence immunoassays for the rapid detection of SARS-CoV-2 antigen-new tool to detect infective COVID-19 patients
Isolation of Ciprofloxacin and Ceftazidime-Resistant Enterobacterales From Vegetables and River Water Is Strongly Associated With the Season and the Sample Type
Selective digestive decontamination with oral colistin plus gentamicin for persistent bacteraemia caused by non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae in a neutropenic patient
The story behind Chile's rapid rollout of COVID-19 vaccination
Tool for Estimating the Probability of Having COVID-19 With 1 or More Negative RT-PCR Results
Covid-19 in South America: clinical and epidemiological characteristics among 381 patients during the early phase of the pandemic in Santiago, Chile
Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples
The human microbiota and infection prevention.
Acquisition of Multidrug-resistant Organisms in the Absence of Antimicrobials.
Fecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile.
[Leprosy=> we figth the disease not those who suffer from it].
[Safety of fluoroquinolones=> risks usually forgotten for the clinician].
Microbial Disruption Indices to Detect Colonization With Multidrug-Resistant Organisms.
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.
Virus Zika en un nuevo mundo.
Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms.
Daptomycin: Pharmacologycal Characteristics and its Role in the treatment of Gram Positive Infections
Bacteremia in patients with liver cirrhosis
Human bocavirus in Chile: clinical characteristics and epidemiological profile in children with acute respiratory infections
Cat scratch disease associated neuroretinitis: clinical report and review of the literature
Pandemic Influenza A (H1N1) 2009 with neurological manifestations, a case series

Editorial (1)

Lepra: combatimos la enfermedad no a los que la sufren

Proyecto (7)

Platforms for Covid-19 surveillance and evaluations of interventions in Chile.
Transforming antimicrobial-resistance Surveillance in Chile
Hospital and community burden of multidrug-resistant gram-negative bacteria in Chile
Nucleo Milenio para la Investigación Colaborativa en Resistencia Bacteriana (MICROB-R)
Determinants for tuberculosis infection acquisition in contacts=> exploring the role of nasopharyngeal mucosal environment.
Rectal microbiome disruption indices associated with acquisition of multidrug- resistant organisms among subjects exposed to antimicrobials
MaucoBiome
16
Rafael Araos

Principal Investigator

Universidad del De

Santiago, Chile

3
Thomas Weitzel

Head Travel Medicine Program

UNIVERSIDAD DEL DESARROLLO

Santiago, Chile

3
Pablo Vial

Professor

School of Medicine

ICIM/UNIVERSIDAD DEL DESARROLLO - CLÍNICA ALEMANA

Santiago, Chile

3
Jose Munita

Profesor Asociado

Internal Medicine

FACULTAD DE MEDICINA CLINICA ALEMANA- UNIVERSIDAD DEL DESARROLLO

Santiago, Chile

2
Gerardo Gonzalez

Full Professor

Microbiology

UNIVERSIDAD DE CONCEPCION

Concepcion, Chile

1
Andres Opazo

Profesor Asistente

Microbiología

Universidad de Concepción

Concepción, Chile

1
Patricia García

Jefe de Laboratorio de Microbiologia

Escuela de Medicina

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE, LABORATORIO DE MICROBIOLOGÍA

Santiago, Chile

1
SANDRA CORTES

ASSOCIATED PROFESSOR

PUBLIC HEALTH

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

1
Aiko Adell

Profesor Asociado

Universidad Andrés Bello

Santiago, Chile

1
Andrea Moreno

Profesor Asociado

Pontificia Universidad Católica de Chile

SANTIAGO, Chile

1
Johanna Acevedo

Profesor asociado investigador

Instituto de Ciencias e Innovación en Medicina (ICIM)

Universidad del Desarrollo

Santiago, Chile

1
Roberto Riquelme

Académico Investigador

Universidad de Las Américas

Santiago, Chile

1
Ximena Aguilera

Full Professor; Director Centro de Epidemiología y Políticas de Salud /Center of Epidemiology and Health Policy

Centro de Epidemiología y Políticas de Salud (CEPS)/ Center of Epidemiology and Health Policy/Centro de Epidemiología y Políticas de Salud (CEPS)

Universidad del Desarrollo

Santiago, Chile

1
Cecilia Gonzalez

Investigadora

Medicina

Universidad del Desarrollo

Las Condes, Chile

1
Paulina González

Asistente investigación

Microbiología

Universidad de Concepción

Concepcion, Chile